Evidence map›Paper›PMID 40556617›Full record

ReviewRejuvenation research2025

Stem Cell Aging and Rejuvenation in the Skeletal Muscle System.

Michela Libergoli, Albert E Almada

Abstract readReview
In one paragraph

Review in Rejuvenation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Editorial: Stem cell therapy for hereditary neuromuscular diseases.Frontiers in cell and developmental biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michela LibergoliDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA.ORCID 0000-0003-4329-3221
Albert E AlmadaDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA.

Funding

Stem Cell Dysfunction in Aged Skeletal MuscleR01AR080753 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Albert Ernesto Almada · 2023 to 2026
$2.2M
NIAMS NIH HHS R01 AR080753
6 · The paper itself

Abstract

Aging is an unavoidable process associated with a progressive decline of muscle mass, strength, and regenerative ability. Satellite cells are a muscle stem cell (MuSC) population that plays a key role in mammalian muscle regeneration, by awakening from quiescence and then migrating to sites of damage, expanding in number to generate progenitor cells, and then either differentiating to rebuild the muscle tissue or self-renewing to repopulate the stem cell pool. Emerging evidence suggests that the aging process impairs the activation potential and the regenerative capacity of MuSCs. This review explores some of the recent discoveries of how mis-regulation of intrinsic and extrinsic mechanisms drive the decline of MuSC function in aging muscles, and we discuss new strategies to rejuvenate aged MuSC function for regenerative medicine. Understanding these processes will speed up the development of novel therapeutics for counteracting muscle loss and improve muscle healing in the elderly.

Indexed as

AgingCellular SenescenceMuscle, SkeletalRejuvenationStem CellsAnimalsHumansRegenerationSatellite Cells, Skeletal Muscleagingmuscle regenerationmuscle stem cellsnicherejuvenationsarcopenia

Identifiers

PMID40556617
PMCPMC12315999

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.